Two weeks ago in Sweden, Syncrosome, your in vivo partner for preclinical studies, participated to the last edition of NLS Days. It was 2 very interesting days spent to discuss with Nordic Companies and learn more about their business models and area of research in multiples field of...
Last month, all the Syncrosome team participated to our annual seminar. Different meetings were organized with a very good participation of everyone on: Satisfactory points and also what need to be improved in 2018 to maintain or improve 90% of customer satisfaction. Next in vivo scientific challenges...
DESCRIPTION DU POSTE : SYNCROSOME est une société de recherche préclinique, spécialisée dans la mise au point de modèles de pathologie afin de proposer aux industriels de tester l'efficacité de leurs candidats médicaments dans différentes indications.Nous travaillons en étroite collaboration avec les scientifiques des groupes pharmaceutiques et...
In the framework of our development, we are proud to announce our political will to strengthen our capabilities for cardiovascular studies by the recruitment of our new scientific colleague, Guillaume Bourdier. He will be in charge, with the scientific and technical team, of managing cardiovascular studies...
Syncrosome were very happy to be selected to participate to the B2B meetings organized by Eurobiomed and met Japanese and American Pharmaceuticals Companies (Link-J and BioCom clusters were present). We had the possibility to exchange on Preclinical studies in Gastrointestinal, Central Nervous System and Cardiovascular area and...
Syncrosome invites you to visit us at Pharmabiotics2018, March 14th to November 15th 2018, in Paris, France. This Conference dedicated to the Microbiome will keep Syncrosome's team up to date in this new area of development! Emmanuelle Bettendorf, our Business Developer would be delighted to meet you...
The 11th ELSCEO Forum will feature 2 days of interactive presentations, poster presentation and networking opportunity, in Zurich (Switzerland) from 26 to 27th of February. This conference will offer a complete programme focusing on Capital Raising and investment opportunities as well as Advanced therapies and Diagnostics for Neurosciences...
As you know Syncrosome is involved in in vivo Preclinical activities since 17 years and we offer robust and well-validated models to our customer to test the efficacy and the distribution of their compounds. We can give you advice about our in vivo efficacy, CNS-PK and...
Syncrosome invites you to visit us at Nutrevent, June 14th to 15th 2017, in Lille, France. Emmanuelle Bettendorf, our Business Developer would be delighted to meet you their and discuss your in vivo preclinical projects with a special offer dedicated to Nutraceutics, Food supplements and Natural...